Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience.

Autor: Svedman FC; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. fernanda.costa-svedman@regionstockholm.se.; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Theme Cancer, Karolinska University Hospital, Stockholm, 171 76, Sweden. fernanda.costa-svedman@regionstockholm.se., Holmsten K; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.; Department of Oncology, Capio S:t Göran Hospital, Stockholm, Sweden., Jawdat F; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Theme Cancer, Karolinska University Hospital, Stockholm, 171 76, Sweden., Hailom W; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Theme Cancer, Karolinska University Hospital, Stockholm, 171 76, Sweden., Alm D; Department of Radiation Oncology, Karolinska University Hospital, Stockholm, Sweden., Grozman V; Department of Radiology, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden., Ullén A; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.; Department of Pelvic Cancer, Genitourinary Oncology and Urology Unit, Theme Cancer, Karolinska University Hospital, Stockholm, 171 76, Sweden.

Publikováno v: Radiation oncology (London, England) [Radiat Oncol] 2024 Jun 16; Vol. 19 (1), pp. 74. Date of Electronic Publication: 2024 Jun 16.

Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.

Autor: Lindberg S; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden. Electronic address: sara.lindberg@ki.se., Grozman V; Section of Thoracic Radiology, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Karlsson K; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Onjukka E; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Lindbäck E; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy Physics and Engineering, Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden., Jirf KA; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden., Lax I; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden., Wersäll P; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Section of Radiotherapy, Department of Cancer, Karolinska University Hospital, Stockholm, Sweden., Persson GF; Section of Radiotherapy, Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Oncology, Herlev-Gentofte Hospital, Herlev, Denmark; Department of Clinical Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Josipovic M; Section of Radiotherapy, Department of Oncology, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Khalil AA; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Møller DS; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Hoffmann L; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark., Knap MM; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark., Nyman J; Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Drugge N; Department of Therapeutic Radiation Physics, Sahlgrenska University Hospital, Gothenburg, Sweden., Bergström P; Department of Oncology, Northern Sweden University Hospital, Umeå, Sweden., Olofsson J; Department of Oncology, Northern Sweden University Hospital, Umeå, Sweden., Rogg LV; Department of Oncology, Oslo University Hospital, Oslo, Norway., Hagen RK; Department of Oncology, Oslo University Hospital, Oslo, Norway., Frøland AS; Department of Oncology, Oslo University Hospital, Oslo, Norway., Ramberg C; Department of Medical Physics, Oslo University Hospital, Oslo, Norway., Kristiansen C; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark., Jeppesen SS; Department of Oncology, Odense University Hospital, Odense, Denmark; Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Nielsen TB; Laboratory of Radiation Physics, Odense University Hospital, Odense, Denmark., Lödén B; Oncology Department, Central Hospital in Karlstad, Karlstad, Sweden., Rosenbrand HO; Oncology Department, Central Hospital in Karlstad, Karlstad, Sweden., Engelholm S; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Haraldsson A; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden., Billiet C; Department of Radiation Oncology, Iridium Netwerk, Wilrijk, University of Antwerp, Antwerp, Belgium., Lewensohn R; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden., Lindberg K; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Theme Cancer, Department of Head, Neck, Lung and Skin Tumors, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Dec 01; Vol. 117 (5), pp. 1222-1231. Date of Electronic Publication: 2023 Jul 08.

Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy.

Autor: Costa Svedman F; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden., Jalsenius M; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden., Grozman V; Section of Thoracic Radiology, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Bergqvist M; Biovica International AB, Uppsala Science Park, Uppsala, Sweden., Söderdahl F; Statisticon AB, Uppsala, Sweden., Rotstein S; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden., Ny L; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden., Egyhazi Brage S; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Helgadottir H; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2022 Sep; Vol. 61 (9), pp. 1116-1120. Date of Electronic Publication: 2022 Sep 09.

Deep learning versus iterative image reconstruction algorithm for head CT in trauma.

Autor: Alagic Z; Department of Diagnostic Radiology, Karolinska University Hospital, 171 76, Stockholm, Sweden. zlatan.alagic@regionstockholm.se.; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, 17177, Stockholm, Sweden. zlatan.alagic@regionstockholm.se., Diaz Cardenas J; Department of Diagnostic Radiology, Karolinska University Hospital, 171 76, Stockholm, Sweden., Halldorsson K; Department of Diagnostic Radiology, Karolinska University Hospital, 171 76, Stockholm, Sweden., Grozman V; Department of Diagnostic Radiology, Karolinska University Hospital, 171 76, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, 17177, Stockholm, Sweden., Wallgren S; Department of Diagnostic Radiology, Karolinska University Hospital, 171 76, Stockholm, Sweden., Suzuki C; Department of Molecular Medicine and Surgery, Karolinska Institutet, 17177, Stockholm, Sweden., Helmenkamp J; Department of Medical Physics and Nuclear Medicine, Karolinska University Hospital, 17176, Stockholm, Sweden., Koskinen SK; Department of Diagnostic Radiology, Karolinska University Hospital, 171 76, Stockholm, Sweden.; Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, 17177, Stockholm, Sweden.

Publikováno v: Emergency radiology [Emerg Radiol] 2022 Apr; Vol. 29 (2), pp. 339-352. Date of Electronic Publication: 2022 Jan 05.

Multiplex immune protein profiling of fine-needle aspirates from patients with non-small-cell lung cancer reveals signatures associated with PD-L1 expression and tumor stage.

Autor: Franzén B; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Viktorsson K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Kamali C; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Theme Cancer, Medical Unit Head and Neck, Lung, and Skin Tumors, Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden., Darai-Ramqvist E; Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden., Grozman V; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Radiology, Karolinska University Hospital, Stockholm, Sweden., Arapi V; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Hååg P; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Kaminskyy VO; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Hydbring P; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Kanter L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Nyrén S; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Radiology, Karolinska University Hospital, Stockholm, Sweden., Ekman S; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Theme Cancer, Medical Unit Head and Neck, Lung, and Skin Tumors, Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden., De Petris L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Theme Cancer, Medical Unit Head and Neck, Lung, and Skin Tumors, Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden., Lewensohn R; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Theme Cancer, Medical Unit Head and Neck, Lung, and Skin Tumors, Thoracic Oncology Center, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: Molecular oncology [Mol Oncol] 2021 Nov; Vol. 15 (11), pp. 2941-2957. Date of Electronic Publication: 2021 May 01.